Putting Patients First: How the FDA Could Use Its Existing Powers to Reduce Post-Market Adverse Events

Copyright © 2012 by the Trustees of Indiana University. Except as may be expressly provided elsewhere in this publication, permission is hereby granted to produce and distribute copies of individual works from this publication for non-profit education purposes, provided that copies are distributed at or below cost, and that the author, source, and copyright notice are included on each copy. This permission is in addition to rights of reproduction granted under Sections 107, 108, and other provisions of the U.S. Copyright Act and its amendments.

The Indiana Health Law Review (ISSN 1549-3199) is the property of Indiana University and is published two times per year by the Indiana University Robert H. McKinney School of Law, which assumes complete editorial responsibility thereof.